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ABSTRACT OF THE THESIS 
HISTOLOGICAL CHARACTERIZATION OF INTER ICTAL EPILEPTIFORM 
DISCHARGES GENERATING BRAIN REGIONS USING A PRECLINICAL 
MODEL OF FOCAL CORTICAL DYSPLASIA 
by 
Abhay Shivaji Deshmukh 
Florida International University, 2015 
Miami, Florida 
Professor Jorge J. Riera, Major Professor 
Current clinical practice of resective surgery in focal epilepsy involves 
electroencephalogram (EEG) brain source imaging to localize irritative brain areas from 
where Inter-ictal epileptiform discharges (IEDs) emerge, useful to localize the seizures-
onset zones. Unfortunately, there are no previous systematic studies to characterize the 
pathophysiological mechanisms and abnormal cellular substrates in these irritative areas 
since histological data are available only from the final resective zones. To address this 
issue we applied a combination of EEG brain imaging described by Bae et al. (2015) 
using cutting-edge technology for high-density scalp EEG in rodents and histological 
analysis on a chronic rat model of focal cortical dysplasia. Post-mortem brain sections 
were stained for anatomical, functional and inflammatory biomarkers. Abnormal 
anatomical structures and increased expression of inflammatory biomarkers were found 
in the irritative regions. We conclude that IED-based brain source imaging can help to 
localize abnormal tissues highly prospective for epileptogenesis.  
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1. INTRODUCTION 
1.1 FOCAL EPILEPSY 
           Epilepsy is a diverse set of chronic neurological disorders characterized by 
seizures. There are several types of epilepsies, but those named focal are the ones of 
special interest for this thesis. Focal or partial epilepsy is characterized by disturbance in 
electrical activity followed by seizures. Typical symptoms include unconsciousness, 
muscle rigidity, loss of muscle tone, convulsions, impairment of sensory functions, and 
automatism. Refractory focal epilepsy is a condition where antiepileptic drugs are 
ineffective against seizures. Focal epilepsies, also classified as partial epilepsies, are in 
many cases refractory. There are two major groups of focal epilepsy: temporal lobe 
epilepsy (TLE) which is more incident in adults and focal cortical dysplasia (FCD) 
which is more incident in children (Battaglia et al., 2009; Cavalheiro et al., 1995; Curia 
et al., 2008). FCD which is the one studied in this thesis results from malformations of 
cortical development that become electrically excitable with time. FCD forms a 
heterogeneous group of cortical malformations of development (Montenegro et al., 
2003) which resemble the following properties. 
1) Cortical architecture abnormalities: Columnar disorganization (formation of 
vertically   oriented microcolumns consisting of at least eight neurons) and alterations in 
6-layered tangential composition of the cortex (Montenegro et al., 2003). 
2)  Cytological abnormalities:  Hypertrophic neurons outside typical location in layer V, 
immature neurons, round or oval cells with large nucleus and thin rim of cytoplasm, 
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absent in matured cortex, dysmorphic neurons with abnormal size and morphology of 
axons and dendrites, as well as increased accumulation of neurofilament proteins, 
balloon cells, usually large cells with ill-defined membrane, single or multiple eccentric 
nuclei and eosinophilic cytoplasm, demonstrating immunohistochemical features of 
neuronal and glial lineage (Montenegro et al., 2003). 
1.2 PRESURGICAL EVALUATION OF FCD PATIENTS 
The primary aim of the presurgical evaluation of patients with refractory focal 
epilepsy is to determine the location of the epileptogenic zone which is a tissue region 
responsible for seizure generation and that has to be removed to stop the seizures. 
Although surface electroencephalography (EEG) recordings are less sensitive than 
intracranial recordings, they still provide the best overview and, therefore, EEG based 
brain source imaging of interictal epileptiform discharges (IEDs) is the most practical 
and efficient method to localize and determine the epileptogenic region (Noachtar et al., 
2009; Verhellen et al., 2007). 
1.3 INTERICTAL EPILEPTIFORM DISCHARGES (IEDS) 
The term “spike discharge” describes a pattern of EEG characterized by a spike 
followed by a wave in epileptic subjects. Spike discharges are observed not only during 
the ictal phases, when subject is experiencing seizures but also during the interictal 
phases, characterized by the absence of seizures. The spike discharges during the 
interictal phase are called as interictal epileptiform discharges. There is no standard 
definition of the IEDs, but are generally classified in typical sub-types as spikes (20-70 
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ms in duration, 15-50 Hz) and sharp-waves (70-200 ms in duration, 5-15 Hz) (Tyvaert 
et al., 2008; Grova et al., 2006; Neymotin et al., 2010).  
1.4 ANIMAL MODEL FOR FCD 
Historically, animal models of epilepsy have been mainly developed in rodents. 
It is because the rat is already the lowest appropriate mammalian preparation to study 
epilepsy. In particular, it has been very difficult to obtain an appropriate animal model 
for focal cortical dysplasia (FCD), as methylazoxymethanol acetate and pilocarpine 
(MAM-PILO) double hit model recently developed (Colciaghi et al., 2011) and 
proposed for our study using Wistar rats (details given in section 2.1). Rat model for 
FCD created by prenatal treatment of methylazoxymethanol acetate (MAM) has a 
potential to mimic the pathological and clinical features of focal epilepsy thus MAM-
PILO model is an important model for FCD. Improvements in the strategies to create 
chronic focal epilepsy in rats and the recent development of cutting-edge technology for 
high-density scalp EEG in small animals make this particular preclinical model 
attractive. 
1.5 IED-BASED BRAIN SOURCE IMAGING (BSI)  
            In this study, 32-channel EEG recordings were collected and analysed from 
chronic rat models of focal cortical dysplasia. In order to determine the candidate tissue 
to be resected in these animal models, IEDs from EEG were selected using their 
characteristic features reported in literature (Bortel et al., 2010) and the IEDs sources 
(irritative zones) were estimated by solving the EEG inverse problem (Kaiboriboon et 
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al., 2012). The inverse problem consists of localizing in the 3D brain space the current 
sources that produce the IEDs. To that end, it is necessary to make some assumptions 
about the nature of these current sources. Standardized low-resolution brain 
electromagnetic tomography (sLORETA) (Pascual-Marqui, et al, 2002) is one such 
model which considers two sources of variation: the variation of the actual sources, and 
if present, variation due to noisy measurements and is based on the assumption that 
multiple sources can be simultaneously active across many locations at a given time. 
With context to our study, sLORETA underlies the concept that neighbouring neuronal 
populations are more likely to undergo synchronous depolarization during spontaneous 
discharge or an evoked response than are non-neighbouring neurons (Verhellen et al., 
2007; Kaiboriboon et al., 2012). However, in practice, a critical issue with the IEDs is 
the inconsistencies in the localization of the epileptic zone in an individual case where 
solutions of inverse problem give the multiple localized regions for a single IED. The 
reasons underlying the inconsistencies in the localization of the epileptogenic zones 
could be due to the errors in the proper classification of IEDs and identification of 
relevant irritative area by using only information in the IED waveform. To avoid such 
inconsistencies we used a specific criterion for source determination, based on 
frequency of sources obtained from localization of each IED subtype. 
The existence of multiple IED-generating sources could also be due to improper 
IED classification. We applied widely recommended methods that classify IED 
subtypes using both spatial and temporal profiles based on a multi-way principal 
component analysis known as parallel factor analysis (PARAFAC) (Fumikazu 
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Miwakeichi et.al, 2004) which is combined with a cluster analysis (Pedreira C, et al., 
2004). This method allows us to decompose the topographic maps and temporal courses 
of IEDs as combination of spatial and temporal atoms to reduce the uncertainly in IED 
classification. 
1.6 HISTOLOGICAL ANALYSIS 
As mentioned earlier, localization of the individual IEDs subtypes was performed 
through the use of the sLORETA (Pascual-Marqui, et al, 2002). In order to analyse this 
methodology, we used histological biomarkers for anatomical, functional, and 
inflammatory indicators known to be affected in epilepsy. At the irritative zones 
identified from localized IEDs, we compared these histological indexes with the 
contralateral cortical region. From histological analysis it was possible to discuss major 
molecular and cellular bases that better correlate with the IEDs associated regions. 
In the past most of the studies have been focused on determining histological 
biomarkers associated with the focal epileptic lesion. In this study we aim to find 
correlates between electrically excitable areas, as determined by applied brain source 
imaging and IEDs, and focal epilepsy specific histological biomarkers. 
1.7 STATEMENT OF RESEARCH 
In spite of recent advances in neuroimaging techniques, current clinical practice 
of resective surgery in focal epilepsy involves EEG brain source imaging to localize 
brain areas named irritatives, from where interictal epileptogenic discharges (IEDs) 
emerge to localize the seizures-onset zones (Noachtar et al., 2009; Verhellen et al., 
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2007). Unfortunately, there are no previous systematic studies available to characterize 
the pathophysiological mechanisms and abnormal cellular substrates in these irritative 
areas since histological data are available only from the final resective zones. To 
address this issue we combined EEG brain source imaging with histological analysis 
from the irritative areas which would be only possible using preclinical animal models.  
1.8 OBJECTIVE AND HYPOTHESIS 
The objective of the project was to characterize the pathophysiological 
mechanisms and abnormal cellular substrates of the irritative areas using a preclinical 
animal model by combining: a) an animal model of FCD, b) a method for EEG brain 
imaging of IED generators, and c) histological data. The following hypothesis was 
tested to meet the objective. 
H1: Chronic focal epilepsy induces abnormal pathophysiological changes in the 
irritative areas; hence these irritative zones are of clinical relevance for pre-surgical 
evaluation of patients with refractory focal epilepsy.       
1.9 SPECIFIC AIMS 
Listed below are the specific aims to test the above mentioned hypothesis. Please refer 
to the chapter: materials and methods for details. 
Aim 1:  To develop a preclinical model of focal cortical dysplasia for Wistar rats. 
Aim 2:  To develop an accurate methodology for performing EEG brain source analysis 
on IEDs. 
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Aim 3: To develop a particular protocol to perform histological analysis on the target      
irritative tissue.  
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2. MATERIALS AND METHODS 
All experimental procedures were approved by and carried out in full 
compliance with the Institutional Animal Care and Use Committee at Florida 
International University (Approval No. 13-004). 
2.1 ANIMAL MODEL PREPARATION 
All male Wistar rats used to create models with focal cortical dysplasia were 
received from Charles River Laboratories. The pharmaco-resistant FCD preclinical 
model was established with male Wistar rats following the protocol described 
previously by Colciaghi et al. In brief, this protocol includes two major steps: first, the 
cortical malformations of this preclinical model were induced prenatally on Embryonic 
Day 15 with two doses of methylazoxymethanol (MAM) injections (15mg/kg maternal 
body weight) 12 hours apart; second, these MAM-treated rats were intra-peritoneally 
(i.p.) injected with pilocarpine (PILO, 300 mg/kg) on post-natal day 28 to induce status 
epilepticus (SE). All MAM-PILO rats were monitored by four investigators (YS, RT, 
AD and JJR) independently to identify the SE marked by occurrence of continuous 
motor seizure activity according to the Racine scale (Racine et.al, 1972). Rats 
experiencing SE received intra-peritoneal phenobarbital (20 mg/kg) 90 min after SE 
onset to reduce mortality, then were hydrated subcutaneously with Lactate Ringer’s 
solution and fed by the investigators to improve the survival rate. Rats not experiencing 
SE were euthanized.  After two weeks from onset of SE, rats were observed for 
occurrence of seizures for one week to confirm the chronic epileptic models. 
Eventually, thirteen MAM-PILO rats survived from this procedure and developed 
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chronic seizures. From this point on, these MAM-PILO rats will be referred to as 
epileptic rats. All epileptic rats were housed in standardized cages at a 12h-12h light-
dark cycle with food and water ad libitum. 
Figure-(1):  Methodology Overview. An overview of the methodology illustrating steps 
involved in brain source imaging and rat brain scaling for further histological analysis. 
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           An overview of the methodology is described in figure-1 with epileptic rat with 
EEG-mini cap placed on scalp for EEG recording. A red marking in EEG trace show an 
IED subtype to be selected followed by illustration of IED subtype clustered from 32-
channel scalp EEG. sLORETA localized sources are shown based on selected IEDs. 
The coordinates of these localized brain sources were scaled with respect to 
experimental brain using Paxinos and Watson atlas as shown in figure-1. 
 
2.2 EEG RECORDING 
There is a difficulty for EEG recording in small animals because of small 
surface area of scalp compared to human scalp. To solve this problem our group has a 
patented technology which provides EEG mini cap with 32 spatial electrodes suitable 
for rodent EEG recording (Riera J, et. al., 2011) as shown in figure-1. Weight of the rat 
was measured before initial anesthesia with isoflurane (5% for initial induction and then 
1-2%, 1 L/min O2, 14 PSI) during all the manipulations. This was followed by shaving 
of rat scalp and fixing rat head in a stereotaxic frame. The scalp was rubbed with 
ethanol (90%) for delipidation and a saline swab was kept on the scalp to keep it wet 
until the cap was fixed. After fixing the rat, dexdomitor (dexmedetomidine 
hydrochloride, 0.25 mg/kg) which is an analgesic was administered intraperitoneally, to 
the rat and isoflurane was gradually reduced to 0.5%. This mixture of dexdomitor and 
low dose of isoflurane does not reduce cortical hemodynamic responses (M. Zao etal.; 
S. Harris et.al 2014). Prior to the recording, each electrode was filled with high 
conductance paste. After fixing the cap on the rat scalp an impendence check was 
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carried out to ascertain the performance of each electrode (Riera J, et al., 2011). With 
this preparation, EEG ongoing activity was recorded (PZ3, Tucker-Davis Technology) 
for a period of thirty minutes. The rat body temperature was maintained using a water-
circulating heating pad (TPZ-0510EA, Texas Scientific Instruments, LLC) with a pump 
(TP700, Texas Scientific Instruments, LLC). The rat body temperature (~37°C), heart 
rate (200-300 beats per minute) and respiration rate (<50 breaths per minute) were 
monitored continuously by PowerLab 8/35 data acquisition device and LabChart 
software (AD Instruments) to assure that level of anesthesia remained stable throughout 
the entire experimental procedures. EEG signals were amplified, filtered (0.5 Hz high-
pass, and 250 Hz low-pass), and digitized (5 kHz sampling rate, 0.5 μV resolution). 
 
2.3 EEG PROCESSING, PARAFAC AND CLUSTER ANALYSIS 
          IEDs that included temporal patterns which are spikes (20-70 ms in duration, 15-
50 Hz) and sharp-waves (70-200 ms in duration, 5-15 Hz), were selected by a 
combination of multiple band-pass/notch filters and an auto-thresholding method from 
the averaged signals of the 32-channel scalp EEG. The unique multi-linear 
decompositions of multi-way arrays of data (more than two dimensions) are possible 
under certain conditions according to the principle of Parallel Factor Analysis 
(PARAFAC) (Sidiropoulos and Bro, 2000). In PARAFAC, the data is decomposed as a 
sum of components (space/frequency/time) for three-way arrays. The important 
improvement in PARAFAC as compared to traditional techniques such as PCA or ICA 
is that the decomposition of multi-way data is unique even without additional 
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orthogonality or independence constraints (Fumikazu Miwakeichi et.al, 2004). Thus we 
employed PARAFAC analysis decomposing the EEG data into space/time/sample 
components along with super paramagnetic clustering (fig. 2), a clustering method from 
statistical mechanics (Pedreira C, et al., 2014). This combination allows identifying 
small but consistent differences in the analysed signals. The IED detection method is 
similar to those reported in human studies (A. Salek-Haddadi et al, 2006; E. Kobayashi 
et al., 2006), as well as animal studies (R. Rathakrishnan et al., 2010; F. Pittau et al., 
2013).  
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Figure-(2): IED Classification. (A) PARAFAC 3D (space/time/sample) clustering based 
on k-mean values. (B) Raster plots representing observed clusters with respect to time. 
(Colors show respective clusters). 
 
         Spikes      Sharp waves 
          Spikes     Sharp waves 
(A) Cluster Cloud Sub-Types 
 
(B) Raster Plots 
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Subsequently, spikes and sharp-waves were separated into multiple sub-types (fig 3), 
using a series of feature extraction and classification methods described previously (R. 
Rathakrishnan et al., 2010; F. Pittau et al., 2013). Each sub-type of IEDs was considered 
as a unique event. Event-related 32-channel EEG potentials were created by averaging 
the EEG data time-locked to the IED onsets within corresponding window size (80-ms 
for spikes and 200-ms for sharp-waves). 
 
2.4 sLORETA INVERSE SOLUTION 
      To define a volume conductor model, the open source software, Brainstorm (Tadel 
F, et al, 2011), was used with the MRI atlas for Wistar rats (Valdez-Hernandez P, et al, 
2011). However, individual rat’s MRI can also be used to generate the volume 
conductor model if available. The input of MRI surface and brain surface were given to 
the software and head surface was generated with default setting. For lead field 
computation scalp and inner/outer skull surfaces based on MRI were generated (Tadel 
F, et al, 2011). The orientation and location of each surface were co-registered with 
respect to the MRI using the visualization option (Tadel F, et al, 2011). Using the rat 
head picture with three reference points acquired immediately after EEG recording, 
their positions were co-registered in the MRI. The same references were used to 
generate the electrode positions as the electrode positions are fixed with respect to 
reference points. Electrode position matrix (N × 3) based on the three reference points 
was generated. Here, N is the number of channels (N = 32) and the column represents 
the corresponding x, y, and z coordinate values. Using the generated channel file, the 
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location of all electrodes was displayed and confirmed. Any misplaced electrodes were 
modified manually (Tadel F, et al, 2011). It was made sure that the final coordinate 
system for the electrode positions coincides with the coordinate system used for the 
MRI and brain surfaces. The conductivity values which satisfy the ratio of skin, skull, 
and brain as 1 : 1/80 : 1 were specified to obtain the lead field matrix based on the 
volume conductor model and the electrode positions already created. sLORETA 
solution (Pascual-Marqui, R. D. 2001) was obtained based on the computed lead field 
matrix and the input EEG signals. By selecting the source estimation method option, the 
inverse solution was obtained and estimated sources were plotted (Tadel F, et al, 2011).      
sLORETA distributed inverse solution was estimated from the event-related potentials 
for each IED sub-type using Brainstorm (fig. 3) (Y. Lu et al.,  2004). For each epileptic 
rat, surgically accessible location for craniotomy was determined based on the source 
locations at the initial phases of each IED sub-type. These source locations were 
believed to be associated with irritative zones. A T2-weighted MRI atlas for Wistar rats 
was used to calculate the electric lead fields (J. Riera et al, 2004). This atlas is defined 
on the Paxinos and Watson’s coordinate system (Y. Zheng et al, 2002). 
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Figure-3: Time series and EEG topography for each IED subtype. Analysis performed   
                at a specific time instance represented by a red line in time series. 
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2.5 HISTOLOGY AND sLORETA CO-REGISTRATION  
           Once estimated sources based on the sLORETA inverse solution were visualized 
in the 3D brain region of the pre-clinical model, the coordinates of the identified target 
irritative regions were scaled using Paxinos and Watson’s Atlas (G. Paxinos and C. 
Waston, 2007) with respect to the rat brains to identify the tissue blocks to perform 
immunohistochemistry. For scaling, known coordinates (0.0) of bregma (B1) and a 
length of a point (L1) (-9.3 mm from B1) from the anterior end were used as reference 
from Paxinos and Watson’s atlas. In the rat brains the length of the point (L2) from the 
anterior end was measured (all length measurements were considered in the anterior to 
the posterior direction). This information was used to determine coordinates of bregma 
in rat brains (B2) and to calculate scaling factor (~0.74 for each rat). Product of scaling 
factor and known distance of the target irritative regions from the bregma (B1) obtained 
from source localization gave us real-time coordinates of target regions in the rat brains. 
Tissue blocks of 3mm thickness around the target region were determined for 
immunohistochemistry. 
Immunohistochemistry of tissues is a powerful tool used to demonstrate the 
presence or absence of an antigen. The immunocytochemical staining of brain tissue can 
be compromised by factors such as time of tissue dissection, type of fixation and storage 
time in fixative.  Sometimes an animal has to go through different research studies 
which make it difficult to obtain fresh brain tissue, or brain tissue that has been in 
fixative for a short time for scientific research purposes and may not be available until 
after several months of fixation. If fixed for longer times, the antigens are masked by 
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crosslinking of proteins by aldehyde over fixation. Proteolytic enzyme predigestion is 
often used to unmask the antigens (e.g., Battiflora and Kopinski, 1986) but the results 
are not satisfactory with over fixed tissue. Shi et al. (1991) described a method of 
antigen retrieval from formalin-fixed, paraffin-embedded human brain sections based on 
microwave heating in metal solutions. However no single methodology is available to 
immunostain all the antigens in rat brains that are fixed for long times.  Here we 
demonstrate a procedure to process and immunostain whole brains of focal epileptic rat 
models that have been fixed for few months to a year and to identify three categories of 
focal epilepsy specific biomarkers namely, anatomical, inflammatory and functional 
with fluorescence immunohistochemistry. 
 
2.5.1 FIXATION AND TISSUE PROCESSING 
      Whole animal perfusion was performed on an epileptic Wistar rat after EEG 
recordings (Gage, G, et al, 2012). The brain was dissected and preserved in fixative (4% 
paraformaldehyde) for few months till brain sources were identified by applying EEG 
source analysis as mentioned before. Prior to immunohistochemical staining brain was 
removed from fixative and washed with distilled water for 3-4 hrs. Following washing, 
rat brain was incubated in a 4% aluminum chloride solution at room temperature for 
about 12 hours before heating in microwave for 10 minutes with 1 minute interval after 
5 minutes. Dimensions of brain were measured before and after heating to calculate 
scaling factor to compensate for shrinking of brain upon heating. Accurate position of 
Bregma was calculated from the scaling factor. Brain tissue was kept in 30% sucrose 
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solution at 40C for cryoprotection prior to the sectioning. After about 3 days when tissue 
sinks in sucrose solution, it was taken out and placed on the solid mold with the coronal 
matrix with slots positioned 1 milimeter (mm) apart. With this mold a 3 mm coronal 
segment of interest of rat brain was cut and positioned at the centre of a cubical plastic 
mold filled with tissue freezing medium which supports the tissue during cryostat 
sectioning because of its highly viscous and water soluble properties. Tissue was then 
snap frozen in liquid nitrogen, plastic mold peeled off and tissue block was loaded on 
cryostat head with the help of specimen disc. Tissue block was allowed to equilibrate at 
-220C for 1 hr. 
 
2.5.2 SECTIONING WITH CRYOSTAT 
     The frozen tissue block was mounted on the cryostat head and its orientation was 
kept in the proper x-y plane with reference to the blade. A well oriented tissue block 
will first meet the blade at the centre of the block. After mounting the chuck with frozen 
tissue embedded in tissue freezing medium, first step was the trimming. The face of 
tissue block needs to be trimmed till a desired depth in the tissue is reached. Each 
clockwise rotation of the hand wheel advanced the mounted tissue block in the coronal 
direction as per the set thickness (30μm). In case of focal epileptic rats, sectioning 
should be precise to the target area as determined from the BOLD signal evoked by 
IEDs. The target area was scaled to real-time coronal coordinates using Paxinos and 
Watson’s Atlas (G. Paxinos and C. Waston, 2007). While sectioning, the coronal  
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coordinates at which serial sections were taken were tracked by thickness and the 
number of section from anterior-to-posterior direction. 
 
2.5.3 IMMUNOHISTOCHEMICAL STAINING 
      Sections on glass slides were rehydrated with 0.01M phosphate buffered saline 
(PBS). The endogenous peroxidase activity was suppressed by incubating the sections 
in 3% hydrogen peroxide and 0.2% Triton X-100 in PBS for 30 minutes. Sections were 
washed and incubated in 3% bovine serum albumin (BSA) in PBS for 1 hour to block 
non specific antibody binding to the tissue before incubation in primary antibodies 
followed by secondary antibodies for 1 hr each. Both the primary and secondary 
antibodies were diluted in PBS.  
       Serial tissue sections of 30μm thickness were double immunostained using a 
principle of sequential immunostaining method as described below. 
1. Permeabilization and endogenous peroxidase blocking step: Apply 0.2% Triton X-       
100 with 3% hydrogen peroxide in 0.01M PBS for 30 minutes. 
2. Wash the sections with PBS for 10 mins minutes. Remove the excess PBS with a 
dropper or pipette. Repeat three times. 
3. Blocking step: Incubate the sections in 3% Bovine Serum Albumin (BSA) in 0.01M 
PBS for 60 minutes to block unspecific binding of the antibodies. 
4. Incubate sections with the first primary antibody in 2% BSA in 0.01M PBS in for 1 
hour at room temperature. 
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5. Decant the first primary antibody solution and wash the cells three times in PBS, 10 
minutes each wash.  
6. Incubate cells with first secondary antibody (labelled with Fluorochrome-1) in 2% 
BSA in 0.01M PBS for 1 hour at room temperature in dark.  
7. Decant the first secondary antibody solution and wash three times with PBS for 10 
minutes each in dark.  
8. Incubate cells with the second primary antibody in 2% BSA in 0.01M PBS in the 
dark for 1 hour at room temperature or overnight. 
9. Decant the second primary antibody solution and wash sections three times with PBS 
for 10 minutes each in dark.  
10. Incubate cells with second secondary antibody (labelled with Fluorochrome-2) in 
2% BSA for 1 hr at room temperature in dark.  
11. Decant the second secondary antibody solution and wash three times with PBS for 
10 minutes each in dark. 
12. Remove excess of the PBS from the sides of the slide and cover slip sections with              
mounting medium (ProLong® Diamond Antifade Mountant). 
               For biomarker staining experiments following biomarker staining protocols were 
applied on serial tissue sections (30μm).  
1. Neurofilament (SMI311) staining. 
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2. TNF-α and GFAP sequential double immunostaining. 
3. HMGB1 and GFAP sequential double immunostaining. 
4. IL-1β and GFAP sequential double immunostaining. 
5. GABAARα6 and Neurofilament (SMI311) sequential double immunostaining. 
6. mGluR5 and GFAP sequential double immunostaining. 
7. NMDAR2B and Neurofilament (SMI311) sequential double immunostaining. 
8. Nissl immunostaining. 
          For data analysis biomarkers were grouped in three categories as anatomical, 
inflammatory and functional biomarkers and details about reagents used are given 
following sections.  
2.5.3.1 ANATOMICAL BIOMARKER STAINING 
       The sections were incubated for 1 hour at room temperature with one of the 
following primary antibody mouse anti-neurofilament (SMI 311, 1:2000). Sections were 
washed and incubated with respective secondary antibody: Bovine anti-mouse IgG (sc-
362246, 1:400). For Nissl staining sections were incubated for an hour with Neurotrace 
stain (N-21480, 1:300) after permeabilization (0.2% Triton X-100) step. 
 
2.5.3.2 INFLAMMATORY BIOMARKER STAINING 
     The sections were incubated for 1 hour at room temperature with one of the 
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following primary antibodies: rabbit anti-IL-1β (sc-7884, 1:300), goat anti-TNF-α (sc-
1350, 1:300), rabbit anti-HMGB1 (ab79823, 1:500). Sections were washed and 
incubated with respective secondary antibodies: donkey anti - rabbit IgG (Alexa Fluor 
680, 1:1000), donkey anti-goat IgG (sc-362255, 1:300), donkey anti - rabbit IgG (Alexa 
Fluor 680, 1:1000). For GFAP staining sections were incubated for an hour with 
primary monoclonal mouse Anti-Glial Fibrillary Acidic Protein-Cya3 (Sigma C9205, 
1:500). 
 
2.5.3.3 FUNCTIONAL BIOMARKER STAINING 
     The sections were incubated for 1 hour at room temperature with one of the 
following primary antibodies: rabbit anti-NMDAR2B (AB1557P, 1:500), goat anti-
mGluR-5 (sc-47147, 1:300), rabbit anti-GABAA Receptor alpha6 (AB 5610, 1:300). 
Sections were washed and incubated with respective secondary antibodies: donkey anti 
- rabbit IgG (Alexa Fluor 680, 1:1000), donkey anti-goat IgG (sc-362255, 1:300), 
donkey anti - rabbit IgG (Alexa Fluor 680, 1:1000). 
 
2.5.3.4 DATA COLLECTION AND ANALYSIS 
            To evaluate the IED-generating irritative regions, localized by using sLORETA 
inverse solution, coronal sections from corresponding cortical region in seven FCD rat 
brains were photographed with a Delta Vision Elite System. Raw images were 
processed using background subtraction feature in Image-J open source software. 
Number of Nissl bodies, perivascular cuffing and number of neuronal processes were 
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counted using cell counter plug-in for Image-J software. Perivascular cuffing structure 
was counted as continuous vasculature visible in photographs. Expression of all other 
epilepsy specific biomarkers were computed as stained area as number of pixels in an 
image after applying frequency threshold to avoid detecting background signal using 
ImageJ software. For Each rat, average of six 20X images spanning cortical thickness 
for each biomarker from target region were considered for analysis. Similarly control 
data were collected and analysed from contra-lateral cortex. In this way target and 
control data was collected from seven chronic epileptic rat brains. To determine the 
distribution of the data, Q-Q plot (probability plot) a graphical method was employed 
where linearity of data suggests normal distribution. Based on the distribution of the 
data, statistical analyses were performed using Paired t-test where data were normally 
distributed and Wilcoxson’s Signed Rank test where data were not normally distributed. 
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3. RESULTS 
3.1 SOURCE LOCALIZATION 
     Once all procedures are properly applied, estimated sources can be visualized in 
3D brain region of the pre-clinical model. Figure 1 (A) show step wise methodology 
applied on preclinical rat models of FCD to determine the estimated source from 
localization of spikes and sharp-waves from IEDs. In addition, Figure-2 and 3 display 
classification of subtype spikes and sharp-waves from IEDs. This methodology was 
successfully applied to seven preclinical rat models and a target irritative region was 
decided for each rat based on the criteria as given in Table-1. For each rat, number of 
clearly classified averaged spikes and sharp-waves were localized separately (IEDs in 
Table-1). Each spike and sharp-wave gave certain localized regions represented by 
assigned numbers (localized structures in Table-1, where structures listed as most 
frequent to least frequent) according to the Paxinos–Watson atlas and the averaged 
MRI. From this data, for each rat most frequently localized region (most frequent 
structure in Table-1) was considered as target irritative region for further histological 
analysis. These results support the capability of the applied methodologies to record 
high-resolution EEG on rats with focal epilepsy and to conduct source analysis using 
the recorded EEG. 
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Table-1: Criteria for source determination 
 
Rat 
 
IEDs Localized  Structures 
Most 
Frequent 
Structure 
Target 
area 
Seizure  
During                      
Recording 
 Spikes Sharp waves 
   LFP EEG 
1882 3 3 
 
67,6,56,50,52,59, 
80,84,63,5,60,34, 
12,82,72 
 
67 M1 LEFT No Yes 
1884 4 3 
 
20,68,82,50,52,19, 
60,6,67,84 
 
20 M2 RIGHT No N/A 
2225 4 5 
 
79,82,52,87,67,80, 
88,19,20,68,6,34, 
43,12,15,53,54 
 
79 
S1BF 
LEFT 
No No 
2223 2 4 
 
43,75,95,76,67,12, 
27,14,31,2,32,69, 
94,92 
 
43 
V1B 
RIGHT 
No No 
1888 2 2 
 
47,80,82,34,79,12, 
14,36,84,32,33 
 
47; 80 
V2MM 
RIGHT;  
S1DZ 
LEFT 
Yes No 
1894 3 3 
 
46,39,19,7,12,96,5, 
45,6,40,35,20,69,3
1,14,55,89,43,44 
 
46 
V2ML 
RIGHT 
Yes No 
1900 3 3 
 
32,52,34,12,68,54, 
69,19,79,53,96,15, 
6,14,5 
 
32 
S1DZ 
RIGHT 
Yes No 
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3.2 ANATOMICAL BIOMARKERS 
    We used Nissl staining with 0.2% triton X-100 and NeuroTrace stain (N21478, 
Invitrogen) method to detect the Nissl bodies which are large granular endoplasmic 
reticulum with rosettes of free ribosomes in the neurons. Nissl bodies show changes 
under various pathological conditions.   
 
 
   Figure-(4):  Anatomical Biomarkers. Nissl & Neurofilament (SMI-311) staining.  
                       Scale bars: 50μm. 
 
           We observed that cortical neurons in the control group showed organized 
orientation compared to Nissl staining observed in target cortex as shown in figure-4. 
We also reported neuronal loss as indicated by number of Nissl bodies (figure-5) 
compared in control and target area (p-value< 0.01). 
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Figure-(5):  Statistical representation of Anatomical biomarkers. Bars represent standard   
                    error of mean (SEM). *P < 0.05; **P<0.01. 
 
           Overexpression of SMI311 positive neurofilaments is another important feature 
in FCD. These neurofilaments targeted with monoclonal anti-SM311 antibody enable to 
identify the presence of abnormally large pyramidal neurons often known as 
cytomegalic neurons, frequently grouped in cell clusters, with increased expression of 
SMI311 positive neurofilaments (figure-4), particularly in the apical dendrites. We 
analysed over expression of SMI311 positive neurofilaments in target area by counting 
the neuronal processes (p-value< 0.01) and by measuring the total area of neuronal 
processes (p-value< 0.01) in comparison with control cortex as presented in figure-5. 
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3.3.1 INFLAMMATORY BIOMARKERS 
      Expression of Glial Fibrillary Acidic Protein (GFAP) is associated with FCD. 
GFAP is a useful marker which was a target for monoclonal anti-GFAP antibody 
(Sigma C9205) to demonstrate the increased glial activity and presence of astrocytes 
which are abnormal in their size and orientation (figure-8) in the pathology of FCD. The 
GFAP expression was quantified by computing total stained area of glial processes (p-
value< 0.01) as shown in figure-10. Neuroinflammation in FCD can be identified by 
release and presence of specific inflammatory agents such as Interleukin 1 beta (IL-1β), 
tumor necrosis factor alpha (TNF-α) in inflamed cortical tissue which activates and 
triggers further immune response.  
 
Fig-(6): Inflammatory Biomarkers. IL-1β, HMGB1 & TNF-α staining.  
            Scale bars: 50μm. 
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Figure-(7): Statistical representation of Inflammatory biomarkers. Bars represent   
                   standard error of mean (SEM). *P < 0.05; **P<0.01. 
 
           Significantly increased expression of IL1β and TNFα in target area was 
demonstrated by comparing stained area with control cortex (p-value< 0.05, p- value< 
0.01 respectively) (figures-6 and 7). Also, IL-1β was found to be colocallized with 
GFAP at perivascular cuffing (figure-8). High mobility group protein 1 (HMGB1) 
secreted by immune cells and inflamed cells as an indicator of cell death during 
neuroinflammatory process. Presence of HMGB1 was confirmed by HMGB1: rabbit 
polyclonal antibody (Pharmigen, 1:100, Maroso et al., 2010). HMGB1 expression was 
found to be significantly increased in target area (p-value< 0.01) (figures-6 and 7). 
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Figure-(8): IL-1β and GFAP Co-registration. Scale bars: 50μm. 
 
3.3.2 PERIVASCULAR CUFFING 
       We report numerous diffuse and patchy areas of infiltration of the cortex and white 
matter by inflammatory cells, predominantly glia defined as perivascular cuffing 
(figures-9). Sections from target area showed intensive perivascular cuffing (p-value< 
0.05) (figure-10) underlined by presence of glial cells around inflamed vasculature. The 
astrocytes were hypertrophied and increased in number. 
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          Figure-(9): Perivascular Cuffing. GFAP staining. Scale bars: 50μm. 
 
Figure-(10): Statistical representation of Perivascular Cuffing. Bars represent standard   
                   error of mean (SEM). **P<0.01. 
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3.4 FUNCTIONAL BIOMARKERS 
          Functional markers are associated with specific post-translational changes in the 
pathology of FCD. Increased glutamate function which is associated with 
hyperexcitability in epileptogenic cortex was analysed with amplified expression of the 
NR2B subunit of the N-methyl-D-aspartate glutamate receptor (NMDR) (p-value< 
0.05) (figures-11 and 12) and expression of group I metabotropic glutamate receptor 5 
(mGluR5) in target area was identified (p-value< 0.001) (figures-11 and 12). NR2B was 
found to be intensively co-localized with neurofilaments in target area (figures-13) 
where as mGluR5 was poorly co-registered with GFAP (figures-14). The inhibitory 
function of gamma-aminobutyric acid (GABA)ergic system was observed by analysing 
the expression of the GABAA-receptor α-6 subunit by directing anti-GABAAr α-6  
rabbit polyclonal antibody against it. We found no significant difference between 
localized and control cortex (figures-11 and 12). 
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Figure-(11): Functional Biomarkers. NR2B, GABAA-r-α-6 & mGluR5 staining.  
                    Scale bars: 50μm. 
 
 
Figure-(12): Statistical representation of Functional biomarkers. Bars represent standard   
                     error of mean (SEM). *P<0.05; ***P<0.001. 
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     Figure-(13): Co-registration of NR2B and SMI-311. Scale bars: 50μm. 
 
 
 
 
       Figure-(14): Co-registration of mGluR5 and GFAP. Scale bars: 50μm. 
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4. DISCUSSION 
 
             The PI has developed several experimental and analytical tools in the past to 
study the Wistar rats. This constitutes the main reason for modifying the (Colciaghi et 
al., 2011) model, which was originally developed using Sprague–Dawley, for Wistar 
rats. Rat model for FCD created by prenatal treatment of methylazoxymethanol acetate 
(MAM) has a potential to mimic the pathologic and clinical features of FCD. We have 
provided extensive evidence for the validity of this chronic epileptic model using EEG 
data (Bae et al., 2015), IED-evoked fMRI response (Song et al., 2015), and intracranial 
recordings (Song et al. 2016). This model gave us insights about the cellular and 
molecular mechanisms of epileptogenesis which are evident with similar markers 
observed human FCD subjects. Unfortunately, this model does not show presence of 
balloon cells (abnormally large neurons with abundant cytoplasm) which are observed 
in human FCD subjects. 
4.1 SOURCE LOCALIZATION 
A methodology to non-invasively record multichannel EEG in a preclinical animal 
model of chronic focal epilepsy is described. The details for the recording and analysis 
procedures are provided. There were key factors to consider achieving successful 
results. First, obtaining high quality signals is essential during EEG recordings. There is 
a lot of evidence about the negative effect of different type of anesthesia on the genesis 
of IEDs which was confirmed by our preliminary experiments where EEG recording 
was performed under isoflurane (2%). These negative effects were significantly absent 
in EEG recordings performed under sedative (0.25mg dexdomitor). For this reason we 
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employed a protocol where anesthesia induction was done with 5% isoflurane during 
animal manipulation phase (i.e. fixing an animal to stereotaxic frame, scalp shaving) the 
reducing isoflurane slowly to 0.5% and obtaining EEG recording under sedative. 
Second, for brain source imaging, generating proper volume conductor model is crucial. 
Each surface of the model should be co-registered. Even though we have applied source 
analysis procedures using Brainstorm (Tadel F, et al, 2011), other open softwares 
(Delorme, A, et al, 2004; Oostenveld R, et al, 2011) and commercial products (Koessler 
L, et al, 2010; Manganotti P, et al, 1998) can be used. Also, besides sLORETA, other 
inverse solutions such as multiple dipole models and Beamformer can be applied 
(Baillet S, et al, 2001). Our results support the importance for a precise classification of 
IED markers from EEG recordings to determine the IED-generating irritative regions in 
a rat with focal epilepsy and further to evaluate their relationship with the underlying 
mechanisms for seizure initiation (Song Y, et al, 2014). In addition, it has been shown 
that EEG source localization for such specific IEDs showed a good correspondence with 
the respective BOLD activation and deactivation regions (Bae J, et al, 2015). 
         We believe that the use of this methodology will produce similar results when 
applied to patients with FCD, in this regard preparing IRB protocols for the evaluation 
of this and other aspects of the methodology in human dataset will be a near future 
prospect. Moreover, the use of preclinical models will help us understand the 
capabilities and limitations of EEG source localization in epilepsy (Birot G, et al, 2014). 
Accurate estimation of brain sources underling epileptogenesis is crucial for therapeutic 
strategies and resective surgical planning. Also, having a standard platform for EEG 
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recording in rats will be useful for the evaluation of the effectiveness of several anti-
epileptic drugs in preclinical trials. The entire methodology presented in this study is 
extendable to other experimental conditions and brain disorders. This methodology has 
been developed for Wistar rats because of the existence of an MRI atlas for this 
particular rat strain. However, it can be applied to other rodent types with respective 
standard format of atlas including mouse (Hawrylycz M, et al, 2014), Sprague-Dawley 
rats (Schweinhardt P, et al, 2003), and Paxinos and Watson rats (Schwarz A, et al, 
2006). We have provided extensive evidence for the validity of the used MAM-PILO 
chronic epileptic model using EEG data (Bae et al., 2015), IED-evoked fMRI response 
(Song et al., 2015), and intracranial recordings (Song et al. 2016).  
4.2 ANATOMICAL BIOMARKERS 
           Hyperexcitability in a neuronal tissue is a pathological condition leading to 
epileptic seizures underlines the focally injured tissue in FCD (Badawy RA, et al, 2012) 
characterized by an abnormal neuronal activity in surrounding cortical tissue 
contributing to epileptogenic region (Schiene K, et al, 1996; Eysel ET, et al, 1991). We 
analyzed morphology and protein expressions of key biomarkers in IED-generating 
irritative areas in FCD with seizures, to investigate the hypothesis that chronic epilepsy 
induces pathological changes in the irritative areas.  We found that the irritative area of 
focal epileptic rats was characterized by the abnormal neurons over expressing 
neurofilaments, as well as reduced neuronal mass demonstrated by Nissl staining. 
Consistent results were reported previously in dysplastic compared to non-dysplastic 
areas in type IIA and IIB FCD, (Thom M, et. al, 2005). 
 39 
 
4.3 INFLAMMATORY BIOMARKERS 
              Recent evidence strongly suggests that glia mediated inflammation plays a role 
in the pathogenesis of seizures and epilepsy (Orrin D, et al, 2013). We found extensive 
reactive gliosis (with altered astrocyte morphology) in localized irritative region which 
corroborates finding that longer chronic epilepsy is associated with more intensive 
reactive gliosis and astrocyte alterations in epileptogenic region, further evidence that 
epilepsy is a progressive pathology (Finardi A, et al, 2013). Astrocytes undergo changes 
in morphology, molecular composition, and proliferation in epileptogenic region. The 
activation of astrocytes includes changes that vary with the severity and chronicity of 
seizure pathology (Sofroniew, M.V, 2009). Reactive astrocytes has been reported in 
animal models of epilepsy and in neural tissue from human patients with mesial 
temporal sclerosis (MTS), focal cortical dysplasia (FCD), tuberous sclerosis complex 
(TSC), Rasmussen’s encephalitis (RE), and glioneuronal tumors (Jabs R, et al. 2008; 
Bauer J, et al, 2007; Binder D, et al, 2006). In case of Rasmussen’s encephalitis, 
epilepsy with chronic brain inflammation, astrocytes are a specific target of immune 
system, particularly cytotoxic T cells (Bauer J, et al, 2007). MTS, the most common 
pathology associated with temporal lobe epilepsy (TLE), is characterized by astroglial 
and microglial activation and proliferation (Wetherington J, et al, 2008), with increased 
complexity of astroglial processes, often approaching glial scar-like formations in late 
stage MTS (Martinian L, et al, 2009). 
             Astrocytes are closely related to the microvasculature and with their endfeet 
ensheathing blood vessels (figure-8 and 9)  known as perivascular cuffing contribute to 
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blood-brain-barrier (BBB) function by releasing chemical signals that help to form and 
maintain tight junctions between endothelial cells, thus regulating the exchange of water 
and molecules between the blood and brain tissue (Orrin D, et al, 2013). We observed 
perivascular cuffings and inflammatory glial nodules in epilepetic rats which were more 
intense in target irritative areas. These structures have been attributed in the past to 
tissue breakdown associated with frequent seizures (Theodore Rasmussen, et al, 1958). 
             The brain microvasculature undergoes several structural, molecular, and 
functional changes in epilepsy.  Vessel proliferation in TLE positively correlates with 
seizure frequency (Rigau V, et al, 2007) and is associated with compromised BBB 
permeability (Rigau V, et al, 2007; Marcon J, et al, 2009). Proinflammatory chemokines 
and cytokines released by inflamed epileptogenic tissue can interact with their 
respective receptors over expressed by brain microvasculature  in epilepsy, thus 
compromising BBB permeability at multiple levels [e.g., by disrupting tight junction 
proteins (Morin-Brureau M, et al. 2011), increased infiltration of leukocytes and viral 
particles through the BBB into the brain parenchyma]. In response to inflammatory 
cytokines, excessive leukocyte trafficking by interacting with adhesion molecules on 
endothelial cells may alter BBB permeability to serum proteins and circulating 
molecules (Fabene P, et al, 2008; Kim J, et al, 2009).  
             Glial cells play a critical role by maintaining balance between proinflammatory 
and anti-inflammatory pathways. Activated glia release cytokines inducing 
transcriptional as well as, post-transcriptional signalling in the astrocytes and other 
immune cells. Immune system and glia including astrocytes release IL-1β and high-
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mobility group box 1 protein which activate nuclear factor kappa B (NF-kB), an 
important regulator of proinflammatory gene expression which has been reported to be 
upregulated in MTS and TSC tissue (Crespel A, et al, 2002; Maldonado M, et al, 2003). 
In case of IL-1β and HMGB1 release, signaling occurs through activation of the pro-
inflammatory IL-1 receptor/Toll-like receptor (IL1R/TLR) system. This system is 
activated in epilepsy models and in human MTS, TSC, and FCD tissue (Vezzani, A. et 
al. 2013; Maroso, M. et al. 2010; Zurolo, E. et al. 2011). Astrocytes help to limit the 
immune response by controlling microglial activation. It has been demonstrated in in-
vitro experimental settings that astrocytes can reduce the production of proinflammatory 
and neurotoxic TNF-α, nitric oxide and reactive oxygen species from microglia to 
inhibit microglial phagocytosis (Tichauer, J. et al. 2007).  However, our results showed 
increased TNF-α staining in target area with lack of colocalization with GFAP 
indicating presence of proinflammatory immune response with neuronal source of 
TNFα. 
              In in-vivo seizure models, astroglial cells are also key sources of anti-
inflammatory molecules such as the IL-1 receptor antagonist (IL-1ra), an endogenous 
competitive IL-1 receptor blocker that controls IL-1β-mediated inflammation. IL-1ra 
has powerful anticonvulsant effects in experimental seizure models (Vezzani, A. et al. 
2000; Auvin, S. et al. 2010; Marchi, N. et al. 2009) and mice over expressing IL-1ra in 
astrocytes were reported to be intrinsically resistant to seizures (Vezzani, A. et al. 
2000).  However, in MTS and experimental epilepsies, astrocyte expression of IL-1ra is 
significantly lower than that of IL-1β (De Simoni, M.G. et al. 2000; Ravizza, T. et al. 
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2006), which may explain poor anti-inflammatory response due to the dominance of 
proinflammatory pathways over anti-inflammatory pathways which we demonstrate to 
be consistent with our finding of IL-1β over expression in epileptogenic region. Also, 
proinflammatory IL-1β was found to be colocallized with GFAP at perivascular cuffing 
(figure-8) indicating active inflammation thus supporting previous study that report 
astrocyte derived interleukin-1 beta (IL-1β) can compromise BBB integrity during 
seizures (Librizzi, L. et al. 2012). 
4.4 FUNCTIONAL BIOMARKERS 
            NMDA receptors (NMDAR) are likely to play an important role in 
epileptogenesis because the NMDAR channels are permeable to Ca2+ which acts as a 
secondary messenger in signalling attributed to synaptic plasticity (Kirkwood A, et al, 
1993; Macdermott A.B., et al, 1986). Several reports are available about increased 
expression of NR2B subunit of NMDA receptor in tissue resected from clinical patients 
with drug-resistant epilepsy (Crino P, et al, 2001; Mathern G, et al, 1998; Najim I, et al, 
2000; Ying Z, et al, 1998; Ying Z, et al, 1999). Mathern et al. (Mathern G, et al, 1998) 
found increased NR2B expression in the hippocampi of epileptic patients. Crino P et al. 
(2001) reported increased NR2B mRNA in dysplastic neocortical neurons in human 
cortical dysplasia. In relevance to these findings, we demonstrate elevated NR2B 
expression in localized irritative zone (figure-11 and 12) with more intense co-
localization of NR2B subunits with neurofilaments (figure-13) in neuronal soma and 
neuronal dendritic processes. 
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             So far, it is clear that cortical injuries are associated with abnormal excitability 
of the adjacent neuronal networks focal epilepsy. It has been assumed that the 
development of this abnormal neuronal activity is the result of an imbalance between 
excitation and inhibition, where changes in inhibition are believed to play the most 
important role (Imbrosci B, et al, 2011). An impaired inhibitory transmission has been 
reported in several animal models of both traumatic and ischemic brain injury 
(Buchkremer-Ratzmann I, et al, 1996; Mittmann T, et al, 1994). Functionally, the 
impaired GABAergic transmission has been attributed to reduction in release of GABA 
from presynaptic terminals (Li H, et al, 2002) and changes in the expression of GABA 
receptors (Schiene K, et al, 1996). In an attempt to assess the inhibitory function at 
localized epileptogenic tissue, we found no significant reduction (figure-12) in 
GABAA-receptor-α6 subunit of GABA receptor family. To reach a proper conclusion 
in this regard we need to analyse the expression profiles of entire GABA receptor 
family and also need to take into account the previous studies (Schiene K, et al, 1996) 
reporting differential GABAergic transmission in and around epileptic foci in 
epileptogenic cortex.  
             Activation and high expression of group I metabotropic glutamate receptors 
(mGluRs) may contribute to neuronal hyperexcitation, as suggested by the convulsant 
action of group I agonists, which are responsible for seizure discharge and 
epileptogenesis in different experimental models (Chapman AG, 1998; Wong R. et al, 
1999). Neuronal mGluRs are known to have important roles in synaptogenesis and 
synaptic plasticity and in pathophysiological processes (Chapman AG, 1998; Merlin L, 
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et al, 1997). In our study we observed elevated expression of mGluR5 (p-value < 0.001) 
in irritative region (figure-11 and 12) with the dominant source being neuronal mass as 
evident from lack of co-localization of mGluR5 with GFAP (figure-14). Since 
consistent findings were reported in similar study involving glioneuronal tumours (GG) 
and dysembryoplastic neuroepithelial tumours from clinical patients associated with 
chronic intractable epilepsy which are highly epileptogenic (Aronica E, et al, 2001), we 
can speculate that chronic seizure activity could contribute to the strong expression of 
mGluR5 in the neuronal component of the tumours although the role of group I 
metabotropic glutamate receptors (mGluRs) is not completely understood (Bruno V, et 
al, 1999; Herrero I, et al, 1998). 
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5. CONCLUSION 
In this study, we applied a standard non-invasive, multiple electrode scalp EEG 
source imaging methodology in preclinical ‘double-hit’ rat models of focal epilepsy. We 
were able to apply this methodology to evaluate preliminarily the underlying brain 
sources of two types of IEDs. Proper classification of EIDs by using only information in 
the IED waveform was performed and sLORETA inverse solution was obtained to 
localize specifically classified IED subtypes. 
         In order to evaluate this methodology using histological biomarkers as gold 
standards, we demonstrated a procedure to process and perform immunohistochemistry 
on brains of chronic focal epileptic rats that have been long time under fixation (for a 
few months to a year). We were successful in immunostaining three categories of focal 
epilepsy specific biomarkers with fluorescence immunohistochemistry. The results 
showed the existence of abnormal neuronal expression as well as glioreactivity, vascular 
cuffing substantial inflammatory processes in irritative brain areas, independent whether 
they were the seizure-onset zones or not. We conclude that chronic focal epilepsy 
induces abnormal pathophysiological changes in the irritative areas; hence these 
irritative zones are of clinical relevance for pre-surgical evaluation of patients with 
refractory focal epilepsy and IED-based brain source imaging helps localize these 
abnormal tissues (irritatives) highly prospective for epileptogenesis.  
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